The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intra-arterial gemcitabine versus intravenous gemcitabine: Pharmacokinetic sub-study of the TIGeR-PaC phase 3 clinical trial.
 
Paula Novelli
No Relationships to Disclose
 
Amer Zureikat
No Relationships to Disclose
 
Michael Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; Merck; Merus; Moderna Therapeutics; Pfizer; Renovo Rx; Seagen; Serna Bio; TriSalus Life Sciences
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Elevation Oncology (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Recursion Pharmaceuticals (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma; Merus; RenovoRx
 
Kenneth Meredith
No Relationships to Disclose
 
Hassan Hatoum
Consulting or Advisory Role - Foundation Medicine
 
Emmanuel Zervos
No Relationships to Disclose
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Akero Therapeutics; Alector; Amgen; ESSA; Exelixis; Johnson & Johnson; Kura Oncology; Macrogenics
 
Sandeep Laroia
No Relationships to Disclose
 
Ramtin Agah
Employment - RenovoRx
Leadership - RenovoRx
Stock and Other Ownership Interests - RenovoRx
Research Funding - RenovoRx
Patents, Royalties, Other Intellectual Property - RenovoRx